SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.
San Diego-based BioMed Realty Trust Inc. (NYSE: BMR) has declared a first-quarter 2014 dividend of 25 cents per share of common stock, equivalent to $1 per share on an annualized basis.
Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.
Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.
U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.
Kaiser Permanente will open a new medical office building in Oceanside on March 17.
AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront
AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.
Happy World Sleep Day.
Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.
BIOTECH: Proactive Patient Got to Work on New Mobility Device
Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.
BIOTECH: Stevenson Is President of New Division
Shepherding thousands of employees through a high-profile merger is highly daunting, but Mark Stevenson considers himself equal to the task. The veteran biotech executive has, after all, done it before.
Vista-based medical device maker DJO Global Inc. has appointed Susan Crawford as the company’s new chief financial officer.
Lumena Pharmaceuticals Inc. has closed a $45 million Series B round, and will use the funding to develop drugs for two diseases of the liver.
Sharp HealthCare has named Ken Lawonn as its new chief information officer. He is replacing Bill Spooner, who retired March 3 after working 35 years for Sharp.